LASER THERAPY FOR CARCINOMA IN SITU OF THE PENIS

Abstract

No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Nov 2001LASER THERAPY FOR CARCINOMA IN SITU OF THE PENIS B.P.J. van BEZOOIJEN, S. HORENBLAS, W. MEINHARDT, and D.W.W. NEWLING B.P.J. van BEZOOIJENB.P.J. van BEZOOIJEN More articles by this author , S. HORENBLASS. HORENBLAS More articles by this author , W. MEINHARDTW. MEINHARDT More articles by this author , and D.W.W. NEWLINGD.W.W. NEWLING More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)65650-9AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Carcinoma in situ of the penis, also referred to as Bowen’s disease or erythroplasia of Queyrat, may lead to invasive squamous cell carcinoma. We assessed the results of laser therapy for carcinoma in situ of the penis. Materials and Methods: From 1986 to 2000 we treated 19 patients with carcinoma in situ of the penis with the neodymium:YAG or carbon dioxide laser. Treatment was assessed retrospectively. No patient was lost to followup. Results: No complications developed and cosmesis was excellent. After 2 to 4 months 3 patients (16%) received repeat treatment because of incomplete disappearance of the lesion. Mean followup was 32 months. True carcinoma in situ recurrent in 5 patients (26%) at an average followup of 25 months (range 6 to 75), while 1 had infiltrating carcinoma. All patients with carcinoma in situ underwent repeat laser treatment. Conclusions: In our experience laser therapy is appropriate initial treatment for carcinoma in situ of the penis with excellent cosmetic and functional results. This therapy is also suited for recurrence without the need for more mutilating therapy. However, the high incidence of recurrence indicates the need for careful followup and patient self-examination. References 1 : Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. J Cutan Dis1912; 30: 241. Google Scholar 2 : Erythroplasie du gland. Bull Soc Franc Derm Syph1911; 22: 378. Google Scholar 3 : Carcinoma in situ of penis. Is distinction between erythroplasia of Queyrat and Bowen’s disease relevant?. Urology1990; 36: 479. Google Scholar 4 : Squamous cell carcinoma of the penis: premalignant lesions. Scand J Urol Nephrol2000; 205: 187. Google Scholar 5 : Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol2000; 163: 100. Link, Google Scholar 6 : Carcinoma of penis. Review of cases treated by surgery and radiation therapy 1960–1977. Urology1981; 18: 149. Google Scholar 7 : Erythroplasia of Queyrat. A clinicopathologic and histochemical study. Cancer1973; 32: 1396. Google Scholar 8 : The management and prevention of premalignant penile lesions. Scan J Urol Nephrol2000; 205: 220. Google Scholar 9 : Treatment of penile intraepithelial neoplasia (PIN) with interferon alpha-2a, CO2 laser (vaporization) and 5-fluorouracil 5% (5-FU). Eur J Gynaecol Oncol1997; 18: 410. Google Scholar 10 : Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol1993; 149: 492. Link, Google Scholar 11 : Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ with a high-energy pulsed carbon dioxide laser. Arch Dermatol1998; 134: 1247. Google Scholar 12 : High- and low-power CO2-lasers; comparison of results for three clinical indications. J Reprod Med1993; 38: 455. Google Scholar 13 : Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology1998; 52: 559. Crossref, Medline, Google Scholar 14 : Sapphire probe laser surgery for localized carcinoma of the penis. Eur J Surg Oncol1988; 14: 193. Google Scholar 15 : Local recurrent tumour after penis-conserving therapy. A plea for long-term follow-up. Br J Urol1993; 72: 976. Google Scholar From the Free University Medical Center and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands© 2001 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byLont A, Gallee M, Meinhardt W, van Tinteren H and Horenblas S (2018) Penis Conserving Treatment for T1 and T2 Penile Carcinoma: Clinical Implications of a Local RecurrenceJournal of Urology, VOL. 176, NO. 2, (575-580), Online publication date: 1-Aug-2006.WINDAHL T, SKEPPNER E, ANDERSSON S and FUGL-MEYER K (2018) SEXUAL FUNCTION AND SATISFACTION IN MEN AFTER LASER TREATMENT FOR PENILE CARCINOMAJournal of Urology, VOL. 172, NO. 2, (648-651), Online publication date: 1-Aug-2004.WINDAHL T and ANDERSSON S (2018) Combined Laser Treatment for Penile Carcinoma: Results After Long-Term FollowupJournal of Urology, VOL. 169, NO. 6, (2118-2121), Online publication date: 1-Jun-2003. (2018) EDITORIAL COMMENTJournal of Urology, VOL. 168, NO. 6, (2421-2421), Online publication date: 1-Dec-2002. Volume 166Issue 5November 2001Page: 1670-1671 Advertisement Copyright & Permissions© 2001 by American Urological Association, Inc.Keywordspenislaserscarcinoma in situMetricsAuthor Information B.P.J. van BEZOOIJEN More articles by this author S. HORENBLAS More articles by this author W. MEINHARDT More articles by this author D.W.W. NEWLING More articles by this author Expand All Advertisement PDF downloadLoading ...